TP53 Loss Elevates NF‐κB‐IFN‐β‐MHC‐Ia Signaling to Promote NK Cell Resistance in Osteosarcoma

Guihui Qin, Cheung Kwan Yeung, Ye Yi, Dejin Zheng, Miaoman Ye, Chi‐Chong Chio, Jinjie Wu, Siyi Fu, Chu‐Xia Deng, Ren‐He Xu · 2026

Read TP53 Loss Elevates NF‐κB‐IFN‐β‐MHC‐Ia Signaling to Promote NK Cell Resistance in Osteosarcoma by Guihui Qin, Cheung Kwan Yeung, Ye Yi, Dejin Zheng, Miaoman Ye, Chi‐Chong Chio, Jinjie Wu, Siyi Fu, Chu‐Xia Deng, Ren‐He Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13564184.txt.

Description

Qin and co-authors ask how loss of the TP53 gene helps bone cancer cells escape natural killer cells. TP53 loss is a key step in osteosarcoma growth, but its effect on immune attack was unclear. The team used human cancer cell lines and stem cell based models of the disease. They also checked single-cell data from patient samples and ran tests in mice.

Cells that lost TP53 raised levels of MHC-Ia, a surface protein that shields them from killer cells. The change ran through a DNA sensing path that switches on NF-kB and interferon beta. Tumors with p53 loss grew more aggressively in mice and drew in fewer killer cells. The results point to a route by which these tumors resist immune attack.

Catalog record

CREATORGuihui Qin, Cheung Kwan Yeung, Ye Yi, Dejin Zheng, Miaoman Ye, Chi‐Chong Chio, Jinjie Wu, Siyi Fu, Chu‐Xia Deng, Ren‐He Xu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13564184

Browse the full library · About the Tower of Babel